The importance of thrombin inhibitors in the antithrombotic pharmacotherapy

Journal Title: Postępy Nauk Medycznych - Year 2010, Vol 23, Issue 10

Abstract

Activation of blood coagulation is a physiological process which consists of a series of zymogens that can be converted by limited proteolysis to active enzymes leading to the generation of thrombin. Trombin is a multifunctional plasma serine protease which has a central role in controlling hemostasis. Trombin is responsible for conversion fibrinogen into fibrin, platelet activation and feedback activation of other coagulation factors. Consequently, control of thrombin generation regulates plasma coagulant activity. For this reason the thrombin inhibition is a key for successful novel antithrombotic pharmacotherapy. Thrombin inhibitors are classified as indirect inhibitors (heparin) and direct inhibitors. Currently for clinical use are available 3 parenteral direct thrombin inhibitors: hirudin and bivalirudin which bind both the catalytic site and exosite I of thrombin, and argatroban which binds only to the active site. The next novel class currently available for clinical use are orally bioavailable direct thrombin inhibitors: ximelagatran and dabigatran which reversible bind only to the active site of thrombin molecule. Clinical studies carried in last years show that the most promising drug is dabigatran, which may be an alternative to vitamin K antagonists. This article describes the thrombin generation mechanisms in vivo as well as mechanism of action and pharmacokinetic of indirect and direct thrombin inhibitors currently available in clinical use.

Authors and Affiliations

Michał Bijak, Mateusz Bobrowski

Keywords

Related Articles

Somatic causes of delirium in elderly patients

Delirium is defined as transient brain dysfunction characterized by altered level of consciousness, impaired attention and cognitive functions as well as fluctuating course. Etiology of delirium is multifactorial, clinic...

Zakażenie Clostridium difficile jako czynnik ryzyka w chirurgii

W pracy została omówiona etiologia, patogeneza, objawy kliniczne i leczenie zakażenia Clostridium difficile. Zwrócono uwagę na wzrastającą częstość występowania zakażenia C. difficile związaną z nadmiernym i niekontrolo...

The role of autologous hematopoietic stem cell transplantation in the treatment of multiple sclerosis

Multiple sclerosis is a chronic disease of the central nervous system with inflammatory and neurodegenerative component and represents one of the leading causes of neurologic disability especially in young adults. Typica...

Skala Klinicznej Oceny Stopnia Otępienia (CDR) a ryzyko otępienia u osób z łagodnymi zaburzeniami poznawczymi

Wstęp. Łagodne zaburzenia poznawcze (ŁZP) to zespół objawów definiowany jako pogorszenie funkcjonowania poznawczego w stopniu większym niż przewidywany dla wieku i poziomu wykształcenia, ale niezakłócający w sposób znacz...

Medicalization of Depression, Anxiety, Schizophrenia, ADHD, Childhood Bipolar Disorder and Tantrums: Scientific Breakthrough, or Broad-Based Delusion?

Clearly, a number of psychological and behavioral disorders arise within our biology. These include autism, Down’s syndrome, those due to toxin exposure, metabolic and endocrine difficulties, and several ot...

Download PDF file
  • EP ID EP53774
  • DOI -
  • Views 162
  • Downloads 0

How To Cite

Michał Bijak, Mateusz Bobrowski (2010). The importance of thrombin inhibitors in the antithrombotic pharmacotherapy. Postępy Nauk Medycznych, 23(10), -. https://europub.co.uk/articles/-A-53774